Skip to main content
Clinical Trials/NCT01731743
NCT01731743CompletedNot Applicable

Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses

Carl Zeiss Meditec AG1 site in 1 country107 target enrollmentStarted: January 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
107
Locations
1
Primary Endpoint
Intermediate visual acuity

Study Overview

Brief Summary

The purpose of the study is to evaluate the far, intermediate and near visual acuities with a trifocal IOL.

Detailed Description

After bilateral cataract surgery, monocular and binocular uncorrected (UCVA) and best distance corrected visual acuity (BCVA) will be measured at far (4m), intermediate (80 cm) and near (40 cm) distance as well as the subjective refraction.

A patient questionnaire will be used to assess the patient satisfaction and spectacle independence.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Man or woman, over 50 years of age
  • •Bilateral implantation of a trifocal intraocular lens
  • •Capsular bag implantation

Exclusion Criteria

  • •Existing ocular pathology
  • •Surgical complications
  • •Corneal astigmatism ≥ 1.0D

Arms & Interventions

implantation of a trifocal IOL (AT LISA tri 839MP)

Other

Intervention: AT LISA tri 839MP (Device)

Outcomes

Primary Outcomes

Intermediate visual acuity

Time Frame: up to 3 months postoperatively

Monocular and binocular uncorrected and best distance corrected

Secondary Outcomes

  • near and far visual acuity(1 and 3 month postoperatively)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials